Excited to share our new publication: Clinical Characteristics, Management and Outcomes of Non-ICU Candidemia – a subanalysis of the ECMM Candida III multinational European cohort study. 😊 academic.oup.com/ofid/articl… @martinhoenigl @SarahSedik @jprattes @CornelyOliver

Clinical characteristics, management and outcomes of non-ICU candidemia: Sub-analysis of the ECMM Candida III multinational European observational cohort study @eurconfmedmycol @Stella_A_I @SarahSedik @EcmmCandidaIV academic.oup.com/ofid/articl…

Update on Candida IV study at #TIMM2025 Still open for registration 🔬🧫🧪 Join now!

Preliminary results of the Candida IV study at #ISHAM2025 Study is still open to join 🔬🥼👩‍🔬

🧫 Persistent candidemia: lessons from a European cohort In 258 patients from 18 countries, 20% had ≥5 days of ( ) cultures → higher mortality (50% vs 32%). Low EQUAL #Candida Scores predicted persistence 💡 Adherence saves lives 🔗 journalofinfection.com/artic…

⏰Only 70 days left to join the ECMM #CandidaIV study! 🌎 A global, multicenter study on non-albicans Candida infections 🔬 Focus: Resistance, tolerance & clinical outcomes in #candidemia 📅 Enrollment open until September 30, 2025 📥 Register now and be part of it!

Proud to present the progress of @EcmmCandidaIV study at #ISHAM2025 @ISHAM_Mycology @eurconfmedmycol Still open for participation!

Exciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: ecmm.info/working-groups/221… ⁦@martinhoenigl⁩ ⁦@Stella_A_I⁩ ⁦@SarahSedik⁩ ecmm.info/working-groups/221…

🎉 Exciting news from #ESCMIDGlobal2025! Proud to present our ECMM Candida IV study Poster at #ESCMID2025! Great discussions and inspring feedback - thanks to everyone who stopped by! #Candida #ClinicalResearch #ESMID #PosterPresentation #Oraltalk

Join our Global ECMM Candida IV Study 🍄 @eurconfmedmycol @EcmmCandidaIV @martinhoenigl @Stella_A_I #ESCMIDGlobal2025

ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @eurconfmedmycol